Progress Being Made Toward Monitoring Glucose Noninvasively
Slow but Steady Progress Being Made Toward Monitoring Glucose Noninvasively
Greystone Research Associates Examines Recent Developments and their Potential Impact on Diabetes Mangement Sector
(Amherst, NH) – When it comes to the diabetes market, there has been no shortage of announcements and pronouncements regarding the ability and forthcoming availability of evolving technology to ease the daily burden faced by diabetes patients. The size and growth forecast for the diabetes management market make it one of the top five healthcare markets. But progress in developing and commercializing a noninvasive glucose monitor (NGM) has been frustratingly slow.
This device sector has long been characterized by small, undercapitalized companies that have struggled to solve the numerous technology issues inherent in attempting to measure analytes through intact skin across an extremely wide range of phenotypes, genotypes and body types. But in the past few years a handful of private firms working to develop NGMs based on well-established technological principles and backed by savvy investors have made progress toward the creation of monitors that are considered to be commercializable.
A comprehensive analysis of noninvasive glucose monitors is the subject of a new and comprehensive report. The report – Noninvasive Glucose Monitors: Devices, Technologies, Players and Prospects - includes assessments of devices, device features, analysis of market factors, profiles of market participants and their activities, and market forecasts.